Navigation Links
NPIL withdraws Parkinson’s dru

It has been reportedly said that Nicholas Piramal India Ltd which imports the raw material and manufactures Madopar, Parkinson’s drug, locally has ceased its production in both vial and tablet form following price control.

The company had approached the National Pharmaceutical Pricing Authority (NPPA) to reconsider its price revision. However, according to NPPA sources the cased was already ‘‘pending review’’ with the Ministry of Chemicals and Fertilisers.

According to NPPA sources the 10 tablet strips came under the price control which the company launched after the price control on vials.// The existing MRP of a 10 tablet strip of 250 mg was Rs 56, whereas the company was seeking an MRP of Rs 97.84 to make it viable for the company.
'"/>




Page: 1

Related medicine news :

1. Canada withdraws ADHD drug Adderall XR
2. Parkinson’s Drug Linked to Gamblin
3. Delaying Parkinson’s Diseas
4. New Drug For Parkinson’s Disease With Less Side Effect
5. Embryonic Cells Might Prevent Parkinson’s Disease From Worsenin
6. Magnetic Stimulation For Parkinson’s Diseas
7. Exercising regularly can reduce the risk of Parkinson’s diseas
8. Fetal Cell Transplant Found To Improve Movement In Patients With Parkinson’s Disease
9. New Medicine For Parkinson’s disease
10. A New Addition Could Help Patients With Parkinson’s Disease
11. Milk intake increases the risk of Parkinson’s disease in midlife
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2017)... Freedom, PA (PRWEB) , ... April 22, 2017 ... ... healthcare experience to his role as Vice President of Sales and Business Development ... of key GPO/IDN business partner engagements, business development, and strategic planning for the ...
(Date:4/21/2017)... ... April 21, 2017 , ... The staff at Palm Beach Face is proud to announce ... the 2017 London Marathon. Set to take place on April 23rd, the London Marathon has ... Schwartz will run as part of team EMPOWER, raising money for the international charity, Smile ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of ... with the 2017 Ruth Ravich Patient Advocacy Award in recognition of her ... was honored with the award at The Beryl Institute’s annual Patient Experience Conference ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... weeklong campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 ... treating and preventing substance use disorders. , The mission of AWARE is ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence that ... Parkinson,s, according to a study released today that will be ... Meeting in Boston , April 22 ... the treatment of Parkinson,s disease, the oral drug levodopa has ... and longevity. But as the disease progresses, the effects of ...
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
Breaking Medicine Technology: